The Drug-Induced Respiratory Disease Website

V.b

Eosinophilic myocarditis

1

Evidence level

low

XVI.e

Alveolar hemorrhage (AH), diffuse AH (DAH)

1

Evidence level

low

XXII.b

Acute lung injury - ARDS

1

Evidence level

low

XXIV.a

Pneumonitis (ILD)

2

Evidence level

possible

XXIV.b

Pneumonitis (ILD), acute and/or severe (may cause ARDS)

2

Evidence level

possible

XXIV.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

XXIV.f

Diffuse alveolar damage (DAD) imaging pattern

1

Evidence level

low

XXIV.h

Pulmonary fibrosis (may improve but partly following drug discontinuation)

1

Evidence level

low

XXIV.j

Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)

1

Evidence level

low

XXVIII.a

Angioedema (may cause UAO, asphyxia and death)

1

Evidence level

low

XXXVIII.k

Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)

1

Evidence level

low